Low level of complement factor H increases the risk of cancer-related death in patients with small-cell lung cancer

Conclusions
CFH can be recognised as a biomarker to predict the risk of death in SCLC. The prediction model established based on CFH, C3 and C4 levels has good accuracy in patients’ prognostic assessment.

Source: Postgraduate Medical Journal - November 22, 2022 Category: General Medicine Authors: Xiang, M., Zhang, H., Kou, L., Chen, J., Xu, Z., He, J. Tags: Original research Source Type: research